0000950170-24-074985.txt : 20240618
0000950170-24-074985.hdr.sgml : 20240618
20240618170007
ACCESSION NUMBER: 0000950170-24-074985
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240616
FILED AS OF DATE: 20240618
DATE AS OF CHANGE: 20240618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Duncan Barbara Gayle
CENTRAL INDEX KEY: 0001353128
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39661
FILM NUMBER: 241052732
MAIL ADDRESS:
STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC.
STREET 2: 18 DESBROSSES STREET
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atea Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001593899
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 460574869
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 FRANKLIN STREET
STREET 2: SUITE 2100
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-204-8109
MAIL ADDRESS:
STREET 1: 225 FRANKLIN STREET
STREET 2: SUITE 2100
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
ownership.xml
4
X0508
4
2024-06-16
0001593899
Atea Pharmaceuticals, Inc.
AVIR
0001353128
Duncan Barbara Gayle
225 FRANKLIN STREET
SUITE 2100
BOSTON
MA
02110
true
false
false
false
false
Common Stock
2024-06-16
4
M
false
33150
0.00
A
33150
D
Restricted Stock Units
2024-06-16
4
M
false
33150
0.00
D
Common Stock
33150
0
D
Restricted stock units convert into common stock on a one-for-one basis.
The restricted stock units are fully vested.
The restricted stock units do not have an expiration date.
/s/ Andrea Corcoran, as Attorney-in-Fact for Barbara Gayle Duncan
2024-06-18